Lipocine Inc (LPCN)
5.07
+0.39
(+8.33%)
USD |
NASDAQ |
May 06, 16:00
5.01
-0.06
(-1.18%)
After-Hours: 20:00
Lipocine Cash and Short Term Investments (Quarterly): 22.04M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.04M |
| September 30, 2023 | 23.85M |
| June 30, 2023 | 25.79M |
| March 31, 2023 | 28.87M |
| December 31, 2022 | 32.53M |
| September 30, 2022 | 34.26M |
| June 30, 2022 | 37.40M |
| March 31, 2022 | 42.00M |
| December 31, 2021 | 44.62M |
| September 30, 2021 | 38.66M |
| June 30, 2021 | 46.64M |
| March 31, 2021 | 45.35M |
| December 31, 2020 | 19.67M |
| September 30, 2020 | 18.80M |
| June 30, 2020 | 18.30M |
| March 31, 2020 | 15.58M |
| December 31, 2019 | 14.07M |
| September 30, 2019 | 11.55M |
| June 30, 2019 | 14.48M |
| March 31, 2019 | 17.52M |
| December 31, 2018 | 15.25M |
| September 30, 2018 | 16.88M |
| June 30, 2018 | 20.09M |
| March 31, 2018 | 27.76M |
| Date | Value |
|---|---|
| December 31, 2017 | 21.47M |
| September 30, 2017 | 25.68M |
| June 30, 2017 | 27.83M |
| March 31, 2017 | 26.80M |
| December 31, 2016 | 26.84M |
| September 30, 2016 | 28.84M |
| June 30, 2016 | 32.94M |
| March 31, 2016 | 38.21M |
| December 31, 2015 | 44.38M |
| September 30, 2015 | 41.79M |
| June 30, 2015 | 43.87M |
| March 31, 2015 | 24.76M |
| December 31, 2014 | 27.67M |
| September 30, 2014 | 31.67M |
| June 30, 2014 | 34.16M |
| March 31, 2014 | 41.77M |
| December 31, 2013 | 45.26M |
| September 30, 2013 | 36.84M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0005M |
| December 31, 2012 | 0.0006M |
| September 30, 2012 | 0.0006M |
| June 30, 2012 | 0.0034M |
| March 31, 2012 | 0.0179M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
11.55M
Minimum
Sep 2019
46.64M
Maximum
Jun 2021
28.13M
Average
25.79M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 327.41M |
| Eliem Therapeutics Inc | 106.80M |
| NovaBay Pharmaceuticals Inc | 3.13M |
| Palatin Technologies Inc | 9.485M |
| iBio Inc | 2.788M |